Wells Fargo
RGLS

Wells Fargo’s Regulus Therapeutics RGLS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-204,314
Closed -$358K 6760
2025
Q1
$358K Buy
204,314
+169,155
+481% +$296K ﹤0.01% 3882
2024
Q4
$55.6K Buy
35,159
+8,574
+32% +$13.5K ﹤0.01% 4958
2024
Q3
$41.7K Buy
26,585
+737
+3% +$1.16K ﹤0.01% 5012
2024
Q2
$46.1K Buy
25,848
+25,706
+18,103% +$45.9K ﹤0.01% 4961
2024
Q1
$409 Buy
142
+2
+1% +$6 ﹤0.01% 5932
2023
Q4
$180 Buy
140
+12
+9% +$15 ﹤0.01% 6193
2023
Q3
$175 Buy
128
+1
+0.8% +$1 ﹤0.01% 6244
2023
Q2
$187 Buy
127
+21
+20% +$31 ﹤0.01% 6412
2023
Q1
$90 Buy
106
+14
+15% +$12 ﹤0.01% 6637
2022
Q4
$126 Buy
92
+2
+2% +$3 ﹤0.01% 6414
2022
Q3
$0 Sell
90
-628
-87% ﹤0.01% 6897
2022
Q2
$1K Sell
718
-6,499
-90% -$9.05K ﹤0.01% 6283
2022
Q1
$2K Buy
7,217
+369
+5% +$102 ﹤0.01% 6340
2021
Q4
$2K Sell
6,848
-237
-3% -$69 ﹤0.01% 6348
2021
Q3
$5K Sell
7,085
-547
-7% -$386 ﹤0.01% 6050
2021
Q2
$6K Buy
7,632
+127
+2% +$100 ﹤0.01% 5957
2021
Q1
$12K Buy
7,505
+180
+2% +$288 ﹤0.01% 5923
2020
Q4
$10K Sell
7,325
-9,480
-56% -$12.9K ﹤0.01% 5752
2020
Q3
$8K Sell
16,805
-737
-4% -$351 ﹤0.01% 5625
2020
Q2
$12K Sell
17,542
-4,555
-21% -$3.12K ﹤0.01% 5480
2020
Q1
$10K Buy
22,097
+6,108
+38% +$2.76K ﹤0.01% 5465
2019
Q4
$14K Sell
15,989
-933
-6% -$817 ﹤0.01% 5513
2019
Q3
$12K Sell
16,922
-255
-1% -$181 ﹤0.01% 5527
2019
Q2
$21K Sell
17,177
-4,954
-22% -$6.06K ﹤0.01% 5430
2019
Q1
$23K Buy
22,131
+4,551
+26% +$4.73K ﹤0.01% 5397
2018
Q4
$16K Sell
17,580
-264,606
-94% -$241K ﹤0.01% 5472
2018
Q3
$55K Sell
282,186
-93,786
-25% -$18.3K ﹤0.01% 5283
2018
Q2
$248K Sell
375,972
-8,566
-2% -$5.65K ﹤0.01% 4758
2018
Q1
$276K Sell
384,538
-7,604
-2% -$5.46K ﹤0.01% 4636
2017
Q4
$407K Sell
392,142
-100,049
-20% -$104K ﹤0.01% 4412
2017
Q3
$615K Sell
492,191
-206,199
-30% -$258K ﹤0.01% 4110
2017
Q2
$688K Sell
698,390
-83,990
-11% -$82.7K ﹤0.01% 3927
2017
Q1
$1.29M Buy
782,380
+93,295
+14% +$154K ﹤0.01% 3498
2016
Q4
$1.55M Buy
689,085
+58,753
+9% +$132K ﹤0.01% 3305
2016
Q3
$2.08M Buy
630,332
+119,668
+23% +$395K ﹤0.01% 2903
2016
Q2
$1.48M Buy
510,664
+102,940
+25% +$298K ﹤0.01% 3148
2016
Q1
$2.83M Buy
407,724
+135,072
+50% +$936K ﹤0.01% 2659
2015
Q4
$2.38M Buy
272,652
+8,615
+3% +$75.1K ﹤0.01% 2818
2015
Q3
$1.73M Buy
264,037
+13,849
+6% +$90.6K ﹤0.01% 3050
2015
Q2
$2.74M Buy
250,188
+67,499
+37% +$740K ﹤0.01% 2834
2015
Q1
$3.09M Buy
182,689
+10,344
+6% +$175K ﹤0.01% 2707
2014
Q4
$2.76M Sell
172,345
-14,932
-8% -$239K ﹤0.01% 2764
2014
Q3
$1.28M Sell
187,277
-20,693
-10% -$141K ﹤0.01% 3281
2014
Q2
$1.67M Buy
207,970
+40,955
+25% +$329K ﹤0.01% 3088
2014
Q1
$1.51M Buy
167,015
+47,247
+39% +$426K ﹤0.01% 3161
2013
Q4
$885K Buy
119,768
+30,437
+34% +$225K ﹤0.01% 3468
2013
Q3
$842K Buy
89,331
+44,317
+98% +$418K ﹤0.01% 3442
2013
Q2
$442K Buy
+45,014
New +$442K ﹤0.01% 3735